ENvue Medical (FEED) Non-Current Deferred Tax Liability (2024 - 2025)

ENvue Medical's (FEED) quarterly Non-Current Deferred Tax Liability came in at $15000.0 in Q4 2025, up 200.0% year-on-year from $5000.0 in Q4 2024, and up 200.0% on a QoQ basis from $5000.0 in Q4 2024.

ENvue Medical (FEED) Non-Current Deferred Tax Liability (2024 - 2025) Analysis & Trends

ENvue Medical (FEED) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $15000.0 in Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 200.0% year-over-year to $15000.0 in Q4 2025; TTM through Dec 2025 was $15000.0, a 200.0% increase from a year earlier, with the FY2025 full-year figure at $15000.0, up 200.0% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 stood at $15000.0, up from $5000.0 in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for FEED reached as high as $15000.0 in Q4 2025 and fell as low as $5000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 ENvue Medical 1.18 Mn -1.09 Mn -55,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 15,000.00
Dec 31, 2025 15,000.00
Dec 31, 2024 5,000.00
Dec 31, 2024 5,000.00